![]() |
![]() |
| Abstract | 99. Jahrestagung der DOG, 29. 9. - 2. 10. 01 im ICC, Berlin |
Anmeldung zur Tagung Registration Grußwort Invitation Themen Topics Allgemeiner Ablauf General overview Wissenschaftliches Programm Scientific program Kurse Courses Symposien Symposiums Frühstück mit Spezialisten Breakfast with specialists Arzthelferinnen-Fortbildung Rahmenprogramm Social program DOG Information DOG Information Allgemeine Informationen General Information Autorenindex Index of Authors Ausstellerliste Exhibitors Sponsoren Sponsors Teilnahmegebühren Registration fees Impressum |
|
| Pressure lowering properties of Unoprostone by influencing the conventional outflow pathway. 1,2Thieme H., 3Lambrou G. E., 2Foerster M. H., 1Wiederholt M. 1Institut für Klinische Physiologie und 2Augenklinik, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Hindenburgdamm 30, 12203 Berlin; 3Novartis Ophthalmics AG, Basel, Switzerland Introduction: Unoprostone, a new Docosanoid not binding to prostaglandin
receptor sites, has been shown to reduce intraocular pressure in patients
with POAG and ocular hypertension by an unknown mechanism. The trabecular
meshwork (TM) an the Ciliary muscle (CM) influence IOP by contractile
mechanisms. Therefore the effect of Unoprostone on contractility was investigated.
|
|
| DOG Homepage | Zurück / Back |
|
|
|